Tuberculosis Vaccines and Therapeutics

The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated inci...

College Hill - international business communications consultancy

College Hill is a growing international business communications consultancy with offices in Europe, China, India, South Africa and the United States. College Hill's wide range of complementar...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Alternative Medicine - news, reports, trials and publications

Traditional Chinese Medicine (simplified Chinese: 中医; traditional Chinese: 中醫; pinyin: zhōng yī: "Chinese Medicine") refers to a broad range of medicine practices sharing common...

SERAPHIN study

SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...

Stronger Exelon Patch Wins FDA Nod

(MedPage Today) -- A transdermal patch delivering rivastigmine (Exelon) at a 40% higher rate than the previous maximum strength has been cleared by the FDA for patients with mild to moderate Alzheimer...

FDA Approves Higher Dose of Exelon Patch

The FDA has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

Novartis wins FDA approval for new dosage strength of Exelon Patch

Novartis has obtained the US Food and Drug Administration (FDA) approval for a new 13.3 mg/24 h dosage strength of its Exelon Patch (rivastigmine transdermal system), designed to treat patients with m...

US FDA approves higher dose of Novartis Exelon Patch

The US FDA has approved a higher, 13.3 mg dose of Novartis' Exelon Patch (rivastigmine transdermal system) for treating patients with mild to moderate Alzheimer's disease. The new, 13.3mg/24 h patch...

FDA backs higher dose of Novartis Exelon Patch for Alzheimer's

The US Food and Drug Administration has approved a higher dose of Swiss drug major Novartis' (NOVN: VX) Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate...

Exelon to sell Maryland power plants to Raven Power for $400 mln

Aug 9 (Reuters) - Exelon Corp said it will sell its three coal-fired power plants in Maryland to Raven Power Holdings for $400 million to fulfill the conditions for its merger with Constellation Energ...

Higher Dose of Novartis Drug Exelon Patch Approved By FDA for Patients With Mild to Moderate Alzheimer's Disease

EAST HANOVER, N.J., Sept. 4, 2012 /PRNewswire/ -- The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild...

Governance and implementation of sports safety practices by municipal offices in Swedish communities.

The objective of this study was to explore whether all-purpose health or safety promotion programmes and sports safety policies affect sports safety practices in local communities. Case study research...

Perfluoroalkyl compounds in dust from Asian, Australian, European, and North American homes and UK cars, classrooms, and offices.

Perfluoroalkyl compounds (PFCs) were measured in dust from Australian, Canadian, French, German, Kazahkstani, Thai, UK, and US homes, and UK cars, classrooms, and offices. Most PFCs were significantly...

Retrospective analysis of 88,429 serum and urine glucose EQA results obtained from professional laboratories and medical offices participating in surveys organized by three European EQA centers between 1996 and 2007.

Abstract Background: The aim of this study was to provide inter-laboratory imprecision comparisons of different groups of diagnostic systems as well as a comparison of professional laboratories with m...

Ventilation, Temperature, and HVAC Characteristics in Small and Medium Commercial Buildings (SMCBs) in California.

This field study of 37 small and medium commercial buildings (SMCBs) throughout California obtained information on ventilation rate, temperature, and heating, ventilating, and air conditioning (HVAC)...

Multiple health care visits related to a pediatric emergency visit for young children with common illnesses.

We aim to describe the number of health care visits before and after pediatric emergency department (PED) visits for common illnesses in a French tertiary pediatric hospital. This was a prospective co...